SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-96-000084
Filing Date
1996-01-09
Accepted
1996-01-09 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENOME THERAPEUTICS CORP. N&PS DEFA14A 97005
  Complete submission text file 0000950135-96-000084.txt   98519
Mailing Address 100 BEAVER STREET WALTHAM MA 02154
Business Address 1OO BEAVER ST WALTHAM MA 02154 6178935007
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: DEFA14A | Act: 34 | File No.: 000-10824 | Film No.: 96502051
SIC: 2835 In Vitro & In Vivo Diagnostic Substances